ALZpath Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$8.41M
- Investors
-
3
ALZpath General Information
Description
Provider of biotechnology and laboratory research services intended to improve the lives of those impacted by Alzheimer's disease. The company offers diagnosis, intervention, and personalized treatment to transform the disease ecosystem and test measures levels of pTau217 in the blood to diagnose in its early stages, enabling healthcare providers to improve timely and accurate detection.
Contact Information
Website
www.alzpath.bioCorporate Office
- 2292 Faraday Avenue
- Carlsbad, CA 92008
- United States
Corporate Office
- 2292 Faraday Avenue
- Carlsbad, CA 92008
- United States
ALZpath Timeline
ALZpath Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC | 21-Jul-2026 | $8.41M | Completed | Generating Revenue | ||
| 3. Early Stage VC | Completed | Generating Revenue | ||||
| 2. Accelerator/Incubator | 21-May-2024 | $1.9M | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 19-Jul-2023 | $1.9M | $1.9M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ALZpath Patents
ALZpath Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260110700-A1 | Methods for remote blood collection, extraction and analysis of neuro biomarkers | Pending | 14-Jul-2023 | ||
| WO-2025019332-A1 | Methods for remote blood collection, extraction and analysis of neuro biomarkers | Inactive | 14-Jul-2023 | ||
| AU-2024235526-A1 | Methods of diagnosing and treating neurodegenerative disorders | Pending | 16-Mar-2023 | ||
| EP-4680633-A1 | Methods of diagnosing and treating neurodegenerative disorders | Pending | 16-Mar-2023 | ||
| US-20260008840-A1 | Methods of diagnosing and treating neurodegenerative disorders | Pending | 16-Mar-2023 | C07K16/18 |
ALZpath Signals
ALZpath Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| StartUp Health | Venture Capital | Minority | ||
| Alzheimers Drug Discovery Foundation | Not-For-Profit Venture Capital | |||
| Stead Impact Ventures and Foundation | Impact Investing | Minority |
ALZpath FAQs
-
When was ALZpath founded?
ALZpath was founded in 2020.
-
Where is ALZpath headquartered?
ALZpath is headquartered in Carlsbad, CA.
-
What is the size of ALZpath?
ALZpath has 11 total employees.
-
What industry is ALZpath in?
ALZpath’s primary industry is Other Devices and Supplies.
-
Is ALZpath a private or public company?
ALZpath is a Private company.
-
What is ALZpath’s current revenue?
The current revenue for ALZpath is .
-
How much funding has ALZpath raised over time?
ALZpath has raised $10.3M.
-
Who are ALZpath’s investors?
StartUp Health, Alzheimers Drug Discovery Foundation, and Stead Impact Ventures and Foundation have invested in ALZpath.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process